The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Calls For More Tier 4 Restrictions As Hospitals Strain Under Covid

Tue, 29th Dec 2020 15:39

(Alliance News) - Pressure is growing for the expansion of the toughest coronavirus restrictions in the face of increasing strain on hospitals in England where the number of patients has surpassed the April peak of the first wave.

Health Secretary Matt Hancock is due to announce any changes to tier areas in a statement to the Commons on Wednesday.

An expert adviser to the government said national coronavirus restrictions are needed to prevent a "catastrophe" amid rising infections, and the head of an organisation representing health trusts said "as much of the country as possible" should go into the harshest Tier 4.

The debate over the reopening of schools after the Christmas break is also continuing, with scientists and school leaders suggesting a delay might be needed amid rising cases.

The government said it is "still planning for a staggered opening of schools" after Christmas but is keeping the approach under constant review,

Professor Andrew Hayward, of the government's New & Emerging Respiratory Virus Threats Advisory Group said he thinks schools will have to return "maybe a little bit later" and reopening would mean "we're going to have to have increased, strict restrictions in other areas of society to pay for that".

Fellow Nervtag member Neil Ferguson said there had been a "balancing act" since lockdown was initially eased to try to keep control of the virus while maintaining "some semblance of normal society" but that the new variant had made it more difficult.

He told BBC Radio 4's World At One programme: "Clearly nobody wants to keep schools shut. But if that's the only alternative to having exponentially growing numbers of hospitalisations, that may be required at least for a period."

Geoff Barton, general secretary of the Association of School & College Leaders, welcomed the government's plans for soldiers to offer remote support for testing in schools, but warned it is unlikely to be enough.

Hayward, professor of infectious diseases epidemiology at University College London, said widespread Tier 4 restrictions – or even higher – are likely to be needed as the country moves towards "near-lockdown".

He told BBC Radio 4's Today programme: "I think we are entering a very dangerous new phase of the pandemic and we're going to need decisive, early, national action to prevent a catastrophe in January and February."

Asked whether a national Tier 4 lockdown should be brought in, NHS Providers deputy chief executive Saffron Cordery told BBC Radio Five Live: "I think we need to see, yes, as much of the country as possible in Tier 4."

She said some trusts are reporting up to three times the number of Covid-19 patients as at the peak of the first wave.

NHS England Chief Executive Simon Stevens has warned that doctors and nurses are "back in the eye of the storm".

Figures from NHS England show there were 20,426 patients in NHS hospitals in England at 0800 GMT on Monday, compared with 18,974 on April 12.

Stevens said: "Many of us have lost family, friends, colleagues and – at a time of year when we would normally be celebrating – a lot of people are understandably feeling anxious, frustrated and tired.

"And now, again, we are back in the eye of the storm with a second wave of coronavirus sweeping Europe and, indeed, this country."

Stevens said there is a "chink of hope" in the various Covid-19 vaccines, with the Oxford/AstraZeneca PLC jab expected to be approved imminently by the Medicines & Healthcare products Regulatory Agency, according to reports.

On Tuesday, 90-year-old grandmother Margaret Keenan, who became the first person in the world to receive the Pfizer Inc vaccine earlier this month following its clinical approval, was given her second dose at Coventry's University Hospital.

The current vaccination target will have to be doubled to two million jabs a week to avoid a third wave of the virus, according to a projection from a London School of Hygiene & Tropical Medicine paper reported by the Telegraph.

Trusts in England were told in a letter just before Christmas to begin planning for the use of Nightingale hospitals, although concerns have been raised around staffing the sites.

One senior doctor said some trusts in London and the South East are considering the option of setting up tents outside hospitals to triage patients.

Emergency medicine consultant Simon Walsh said staff are working in "major incident mode" and called on the government to set out a "coherent plan" to get through the coming weeks.

Paramedics in London are receiving support from other ambulance services in the South as they receive up to 8,000 emergency 999 calls each day.

South Central Ambulance Service said it is "pre-warning" the military and fire service that paramedics may need help after an average increase of 10% in 999 calls over the Christmas period and a threefold rise in 111 calls, along with a 60%-70% increase in absence rates with staff symptomatic or self-isolating.

The government said a further 357 people had died within 28 days of testing positive for Covid-19 as of Monday, taking the UK total to 71,109.

The number of further lab-confirmed cases recorded in a single day in the UK also hit a new high of 41,385 at 9am on Monday, rising above 40,000 for the first time, according to Government figures.

The true number is likely to be higher because figures do not include information from Scotland and Northern Ireland, which did not report data between December 24 and 28.

It is not possible to make direct comparisons with the level of infection during the first wave of the virus, because mass testing was only introduced in the UK in May, but it has been estimated there may have been as many 100,000 cases a day at the peak in late March and early April.

More than six million people in east and south-east England went into the highest level of restrictions on Saturday, meaning 24 million – 43% of the population – are now affected.

Lockdown measures are also in place across the other three home nations, after mainland Scotland entered Level 4 restrictions from Saturday for three weeks, and a similar stay-at-home order is in place in Wales.

Northern Ireland has also entered a new six-week lockdown, and the first-week measures are the toughest yet, with a form of curfew in operation from 8pm, shops closed from that time and all indoor and outdoor gatherings prohibited until 6am.

source: PA

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.